Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 12/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 1.00 |
| ▸ | LMNA | P02545 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 8/20 | 0.83 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.83 |
| ▸ | HPGD | P15428 | 4/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.83 |
| ▸ | MEN1 | O00255 | 3/20 | 0.83 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.83 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.83 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.83 |
| ▸ | SLC22A8 | Q8TCC7 | 2/20 | 0.83 |
| ▸ | SLC22A11 | Q9NSA0 | 2/20 | 0.83 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.83 |
| ▸ | RECQL | P46063 | 1/20 | 0.83 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.83 |
| ▸ | POLB | P06746 | 3/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | APEX1 | P27695 | 2/20 | 0.64 |
| ▸ | GLA | P06280 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cefalonium SCHEMBL28323454 | 0.99 | TDP1 (0.98) | TDP1HSD17B10LMNAMAPTKDM4E | |
| Cefalonium SCHEMBL28419781 | 0.99 | TDP1 (0.98) | TDP1HSD17B10LMNAMAPTKDM4E | |
| Cefalonium SCHEMBL28172994 | 0.99 | TDP1 (0.98) | TDP1HSD17B10LMNAMAPTKDM4E | |
| Cefalonium SCHEMBL28295839 | 0.98 | TDP1 (0.95) | TDP1HSD17B10LMNAMAPTKDM4E | |
| Cefalonium SCHEMBL11187482 | 0.93 | TDP1 (0.86) | TDP1HSD17B10LMNAMAPTKDM4E | |
| Cefalonium SCHEMBL11187484 | 0.93 | TDP1 (0.86) | TDP1HSD17B10LMNAMAPTKDM4E | |
| Cephaloridine SCHEMBL3936 | 0.91 | TDP1 (1.00) | TDP1HSD17B10LMNAMAPTKDM4E | |
| Cephaloridine SCHEMBL10665308 | 0.91 | TDP1 (1.00) | TDP1HSD17B10LMNAMAPTKDM4E | |
| Cephaloridine SCHEMBL10665298 | 0.91 | TDP1 (1.00) | TDP1HSD17B10LMNAMAPTKDM4E | |
| Cephaloridine SCHEMBL2908926 | 0.91 | TDP1 (1.00) | TDP1HSD17B10LMNAMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3098 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637481-B2 | Boronic acid derivatives and therapeutic uses thereof | QPEX BIOPHARMA, INC. (US) | 2026-05-26 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| US-12371429-B2 | Antibiotic resistance-modifying tricyclic heteroaryl compounds and uses thereof | RECREO PHARMACEUTICALS LLC (US) | 2025-07-29 | — | — | US | claimed |
| US-20250222118-A1 | Beta-Lactam-Cannabinoid Conjugate Molecules | DIVERSE BIOTECH INC (US) | 2025-07-10 | — | — | US | claimed |
| US-12251417-B2 | Antimicrobial compounds from the genus Delftia | MINISTRY OF HEALTH, STATE OF ISRAEL (IL) | 2025-03-18 | — | — | US | claimed |
| WO-2024240173-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2024-11-28 | — | — | WO | claimed |
| US-20040033938-A1 | Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis | PHARMACIA CORPORATION | 2004-02-19 | — | — | US | claimed |
| EP-1372699-A1 | METHOD OF IMPROVING THE GROWTH PERFORMANCE OF AN ANIMAL | THE UNIVERSITY OF SYDNEY (AU) | 2004-01-02 | — | — | EP | claimed |
| US-20030219461-A1 | Parenteral combination therapy for infective conditions | PHARMACIA CORPORATION | 2003-11-27 | — | — | US | claimed |
| WO-2002096216-A1 | A METHOD OF IMPROVING THE GROWTH PERFORMANCE OF AN ANIMAL | THE UNIVERSITY OF SYDNEY (AU) | 2002-12-05 | — | — | WO | claimed |
| WO-2002067979-A1 | METHOD OF IMPROVING THE GROWTH PERFORMANCE OF AN ANIMAL | THE UNIVERSITY OF SYDNEY (AU) | 2002-09-06 | — | — | WO | claimed |
| US-5415867-A | Complexes with cephalosporins as bactericides | THE LIPOSOME COMPANY, INC. (US) | 1995-05-16 | — | — | US | claimed |
| EP-0414806-B1 | HIGH RATIO ACTIVE AGENT:LIPID COMPLEX | LIPOSOME CO INC (US) | 1994-07-20 | — | — | EP | claimed |
| EP-0414806-A4 | HIGH RATIO ACTIVE AGENT:LIPID COMPLEX | — | 1991-11-13 | — | — | EP | claimed |
| EP-0414806-A1 | HIGH RATIO ACTIVE AGENT:LIPID COMPLEX. | LIPOSOME CO INC (US) | 1991-03-06 | — | — | EP | claimed |
| WO-1989011272-A1 | HIGH RATIO ACTIVE AGENT:LIPID COMPLEX | THE LIPOSOME COMPANY, INC. (US) | 1989-11-30 | — | — | WO | claimed |